MedTrace Logo

Metal Panel Allergen Patch Test Study

NCT04500834 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-02-13

No results posted yet for this study

Summary

Metal allergen patch test study.

Conditions

  • Atopic Dermatitis Eczema

Interventions

BIOLOGICAL

Metal Panel T.R.U.E. Test

Diagnostic patch test

Sponsors & Collaborators

  • Allerderm

    lead INDUSTRY

Principal Investigators

  • Curt Hamann, M.D. · Allerderm (dba SmartPractice)

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-07
Primary Completion
2025-03-31
Completion
2025-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04500834 on ClinicalTrials.gov